Michael F. Huang - 21 Jan 2026 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
21 Jan 2026
Net transactions value
$0
Form type
4
Filing time
23 Jan 2026, 18:02:38 UTC
Previous filing
17 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huang Michael F. Sr. VP of Clinical Development 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY /s/ Anish Bhatnagar, Attorney-in-Fact 23 Jan 2026 0002019992

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +10,400 +29% $0.000000 46,405 21 Jan 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +11,900 $0.000000 11,900 21 Jan 2026 Common Stock 11,900 $43.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 100% of the RSUs shall vest on December 15, 2027, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through such date.
F2 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3 1/48th of the shares subject to the option shall vest on February 1, 2026 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.